Commercial Migrated Member Prior Authorization List
This Prior Authorization List includes services and supplies that require prior authorization or notification for migrated Group, Individual and Administrative Services Only (ASO) members.
This program applies to migrated members only. Review other authorization requirements for non-migrated members.
This Prior Authorization List includes services and supplies that require prior authorization or notification for migrated Group, Individual and Administrative Services Only (ASO) members.
Expedited requests
Submit requests via Availity Essentials when the member or provider believes waiting for a decision under the standard time frame could place the member's life, health or ability to regain maximum function in serious jeopardy. Read the information carefully to ensure your request meets the qualifications, then check the box on the form to attest that it is an expedited request.
Medical services
All medical services prior authorization requests and supporting clinical documentation should be submitted electronically via Availity Essentials: Patient Registration>Authorizations & Referrals>Authorizations.
Request forms will be available by Dec. 1, 2026. Do not submit via fax unless they meet fax exception criteria as defined on the request form.
Physical Medicine program
DME and facilities
The following forms will be available by Dec. 1, 2026:
Behavioral health facilities
The following forms will be available by Dec. 1, 2026:
Request status
Check the status of your requests using the same platform you used to submit the request:
Direct clinical information reviews (MCG Health)
For select CPT codes, Availity's electronic authorization tool automatically routes you to MCG Health's website where you can document specific clinical criteria for your patient. If all criteria are met, you will see the approval on the Auth/Referral Dashboard soon after you click submit. Once all criteria are documented, you will then be routed back to Availity Essentials to attach supporting documentation and submit the request. Documenting complete and accurate clinical information for your patients helps to reduce the overall time it takes to review a request. View the services that may receive automated approval.
| Type of service or request | Online | Phone | Fax (only if unable to submit online) |
Skilled nursing facility only | Submit an electronic prior authorization request through Availity Essentials | 1‑844‑600‑4376 | 1‑833‑847‑6601 |
Long term acute care and inpatient rehabilitation | 1‑800‑423‑6884 | 1‑833‑847‑6601 | |
Chemical dependency and mental health | 1‑800‑780‑7881 | 1‑833‑847‑6601 | |
Transplants | 1‑800‑423‑6884 | 1‑833‑847‑6601 | |
Professional services and DME | 1‑800‑423‑6884 | 1‑833‑847‑6601 | |
Expedited requests | 1‑800‑423‑6884 | 1‑833‑847‑6601 | |
Concurrent review notification for:
| 1‑800‑351‑2370 | 1‑833‑847‑6601 | |
Admission or discharge notifications for inpatient hospital | 1‑833‑847‑6601 | ||
Admission or discharge notifications for SNF/IPRL/LTACH | 1‑800‑423‑6884 | 1‑833‑847‑6601 | |
Clinical records for:
| 1‑800‑423‑6884 | 1‑833‑847‑6601 | |
Physical Medicine program
Codes requiring authorization are listed in the Physical Medicine section below. Determine whether your patient's plan participates in this program by using the Electronic Authorization application on Availity Essentials. View EviCore's clinical guidelines.
Obtain or verify an authorization with EviCore by Evernorth (EviCore):
Members of some group health plans may have terms of coverage or benefits that are different from this information. Refer to the Important Prior Authorization Reminders section for details. To verify coverage or benefits or determine pre-certification or prior authorization requirements for a particular member, call 1-800-676-BLUE (2583) or send an electronic inquiry through your established connection with your local Blue plan.
Online
Phone
Call BlueCard Eligibility at 1-800-676-BLUE (2583). You will be asked for the member's prefix and the type of service for which you are calling:
Upon making your selection, you will be connected to the appropriate Blue plan.
Electronic inquiry
Submit an ANSI 278 transaction (referral/authorization) to BCBSND.
| Type of review | Standard turnaround timeframe for decisions | Additional time allowed for review if additional information is needed: |
Urgent prior authorization |
|
|
Standard initial prior authorization |
|
|
Concurrent review |
|
|
*Note that additional timeframes for review are after receipt of the requested documentation or after the timeframe for submission of the requested information has expired - whichever comes first. | ||
Urgent/expedited criteria is defined as one or more of the following:
Note: If a prior authorization request is received requesting urgent/expedited review, and the documentation provided does not meet the urgent/expedited criteria, the review will be reclassified to a standard review and standard timeframes will apply.
Failure to secure approval for services subject to prior authorization or concurrent review authorization before providing services may result in claim non-payment and provider write-off. Our members must be held harmless and cannot be balance billed.
Please note the following:
See the mental health and substance use disorder section for information about inpatient admissions for chemical dependency and mental health.
Habilitative inpatient services
Hospital admissions
Inpatient hospice
Long-Term Acute Care Facility (LTAC)
Rehabilitation
Skilled Nursing Facility (SNF)
Prior authorization or notification is required for the services listed below. For select CPT codes, including transcranial magnetic stimulation services, Availity Essential's electronic authorization tool automatically connects to MCG Health's website where specific clinical criteria can be documented for your patient. If all criteria are met, approval will be received on the Auth/Referral Dashboard.
Behavioral health criteria:
Administrative Guidelines to Determine Dental vs Medical Services
Custom-Fitted Intra-Oral Appliances for Obstructive Sleep Apnea (Medical policy will be published here by Oct. 1, 2026)
Dental and orthodontic services for the treatment of craniofacial anomalies (PDF)
Enteral and Oral Nutrition Therapy in the Home Setting (PDF)
Bone Growth Stimulators, Electrical (Osteogenic Stimulation)
Ultrasonic Bone Growth Stimulators (Osteogenic Stimulation)
Definitive Lower Limb Prostheses
Insulin Infusion Pumps, Automated Insulin Delivery and Artificial Pancreas Device Systems
Myoelectric and Microprocessor Prosthetic and Orthotic Components for the Upper Limb
Noninvasive Ventilators in the Home Setting
Power Wheelchairs: Group 2 and Group 3
Tumor Treatment Field Therapy (PDF)
Genetic Testing for Alzheimer's Disease - GT01
Apolipoprotein E for Risk Assessment and Management of Cardiovascular Disease - GT05
Genetic Testing for Lynch Syndrome and APC-associated and MUTYH-associated Polyposis Syndromes - GT06
Genetic Testing for Cutaneous Malignant Melanoma - GT08
Cytochrome p450 and VKORC1 Genotyping for Treatment Selection and Dosing - GT10
Familial Hypercholesterolemia - GT11
KRAS, NRAS and BRAF Variant Analysis and MicroRNA Expression Testing for Colorectal Cancer - GT13
Preimplantation Genetic Testing of Embryos - GT18
IDH1 and IDH2 Genetic Testing for Conditions Other Than Myeloid Neoplasms or Leukemia - GT19
Genetic and Molecular Diagnostic Testing - GT20
Biallelic RPE65 Variant-Associated Retinal Dystrophy - GT21
Gene Expression Profiling for Melanoma - GT29
BRAF Genetic Testing to Select Melanoma or Glioma Patients for Targeted Therapy - GT41
Diagnostic Genetic Testing for FMR1 and AFF2 Variants (Including Fragile X and Fragile XE Syndromes - GT43
Genetic Testing for CADASIL Syndrome - GT51
Diagnostic Genetic Testing for α-Thalassemia - GT52
Primary Mitochondrial Disorders - GT54
Targeted Genetic Testing for Selection of Therapy for Non-Small Cell Lung Cancer (NSCLC) - GT56
Myeloid Neoplasms and Leukemia - GT59
PTEN Hamartoma Tumor Syndrome - GT63
Evaluating the Utility of Genetic Panels - GT64
Genetic Testing for Methionine Metabolism Enzymes, including MTHFR - GT65
Diagnosis of Inherited Peripheral Neuropathies - GT66
Genetic Testing for Rett Syndrome - GT68
Duchenne and Becker Muscular Dystrophy - GT69
Fetal Red Blood Cell Antigen Genotyping Using Maternal Plasma - GT74
Genetic Testing for Macular Degeneration - GT75
Whole Exome and Whole Genome Sequencing - GT76
Genetic Testing for Heritable Disorders of Connective Tissue - GT77
Invasive Prenatal Fetal Diagnostic Testing for Chromosomal Abnormalities - GT78
Genetic Testing for the Evaluation of Products of Conception and Pregnancy Loss - GT79
Genetic Testing for Epilepsy - GT80
Reproductive Carrier Screening for Genetic Diseases - GT81
Expanded Molecular Panel Testing of Cancers to Select Targeted Therapies - GT83
Genetic Testing for Neurofibromatosis Type 1 or 2 - GT84
ClonoSEQ® Testing for the Assessment of Measurable Residual Disease (MRD) - GT88
Visit MCG's website for information on buying their criteria or contact the Provider Contact Center at 1-800-368-2312 and we will be happy to provide you with a copy of the specific guideline.
Laboratory Tests for Organ Transplant Rejection
Measurement of Serum Antibodies to Selected Biologic Agents
Assisted Reproductive Technologies (Medical policy will be published here by Oct. 1, 2026)
Bioengineered Skin and Soft Tissue Substitutes and Amniotic Products
Charged-Particle (Proton) Radiotherapy
Digital Therapeutic Products for Attention Deficit Hyperactivity Disorder
Digital Therapeutic Products for Chronic Low Back Pain
Digital Therapeutic Products for Substance Use Disorders
Digital Therapeutic Products for Amblyopia
Digital Therapeutic Products for Post-traumatic Stress Disorder and Panic Disorder
Electromagnetic Navigation Bronchoscopy
Gender Affirming Interventions for Gender Dysphoria
Intensity Modulated Radiotherapy (IMRT)
Progenitor Cell Therapy for the Treatment of Damaged Myocardium Due to Ischemia
Proton Beam (Medical policy will be published by Oct. 1)
In Vivo Analysis of Colorectal Lesions
View pharmacy prior authorization requirements and clinical criteria for updates and changes in 2027. Updated policies for migrated members will be available there on Jan. 1, 2027.
We partner with EviCore by Evernorth (EviCore) to administer our Physical Medicine program.
How to submit an authorization
Online: Use EviCore's portal for the fastest submission option
Phone: Call 1-855-252-1115
Fax: 1-855-774-1319
If one submission option is unavailable, use the next available option. If all submission options are unavailable, submit affected authorization requests within two days after systems are restored.
Retroactive authorization requests are accepted for dates affected by the outage. Retroactive requests are still subject to member eligibility and medical necessity review.
Joint management
Spine
Adipose-derived Stem Cell Enrichment in Autologous Fat Grafting to the Breast
Autologous Chondrocyte Implantation for Focal Articular Cartilage Lesions
Balloon Ostial Dilation for Treatment of Sinusitis
Blepharoplasty, Repair of Blepharoptosis, and Brow Ptosis Repair
Bone Lengthening (Distraction Osteogenesis) (Medical policy will be published by Oct. 1)
Cosmetic and Reconstructive Procedures
Corneal Cross-Linking
Devices for Treatment of Benign Prostatic Hyperplasia, Urethral Stricture, and Urethral Stenosis
Gastric Electrical Stimulation
Interspinous and Interlaminar Stabilization and Distraction Devices (Spacers)
Implantable Peripheral Nerve Stimulation and Peripheral Subcutaneous Field Stimulation
Laser Treatment for Port Wine Stains
Left-Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation
Mastectomy as a Treatment of Gynecomastia
Pectus Excavatum and Carinatum Surgery
Phrenic Nerve Stimulation for Central Sleep Apnea
Reconstructive Breast Surgery/Mastopexy, and Management of Breast Implants
Sacral Nerve Neuromodulation (Stimulation) for Pelvic Floor Dysfunction
Spinal Cord and Dorsal Root Ganglion Stimulation
Spinal Surgery - Cervical Fusion
Spinal Surgery - Lumbar Fusion
Spinal Surgery - Percutaneous Vertebroplasty, Kyphoplasty, Sacroplasty, and Coccygeoplasty
Spinal Surgery - Artificial Intervertebral Disc
Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy
Surgical Treatment for Lymphedema and Lipedema
Surgeries for Snoring, Obstructive Sleep Apnea Syndrome, and Upper Airway Resistance
Transcatheter Heart Valve Procedures for Mitral or Tricuspid Valve Disorders
Transcutaneous Bone Conduction and Bone-Anchored Hearing Aids
Transplants - Stem Cell
Transplants - Islet Transplantation
Transplants - Lung and Lobar Lung
Transplants - Small Bowel, Small Bowel/Liver, and Multivisceral Transplant
Transplants - Liver Transplant
Transplants - Pancreas Transplant
Ventricular Assist Devices and Total Artificial Hearts
Blue Cross Blue Shield of North Dakota is an independent licensee of the Blue Cross Blue Shield Association, serving residents and businesses in North Dakota. All rights reserved.
© 2026 Blue Cross Blue Shield of North Dakota
Please wait while your form is being submitted